Earnings Outlook For Rigel Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Rigel Pharmaceuticals (NASDAQ:RIGL) is scheduled to release its quarterly earnings report on Tuesday, 2024-03-05, with analysts estimating an EPS of $-0.03. The company's past earnings performance shows a pattern of beating EPS estimates, leading to varying stock price changes. Shares were trading at $1.55 as of March 01, with a 1.02% increase over the last 52 weeks. Investors are looking for not only an earnings beat but also positive guidance for the next quarter.
March 04, 2024 | 6:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rigel Pharmaceuticals is anticipated to report an EPS of -$0.03 for the quarter. Historical data suggests that earnings beats positively influence its stock price. The stock has seen a 1.02% increase over the last year.
Given Rigel Pharmaceuticals' history of beating EPS estimates and the subsequent positive stock price movements, there is a reasonable expectation for a short-term positive impact on RIGL's stock price if they beat the EPS estimate again and provide positive guidance. The anticipation of this event, based on past performance, suggests a likely increase in stock price, especially considering the stock's positive trajectory over the last year.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100